Markets Stocks Economy Crypto Earnings Banking Energy
Home Markets Feature
Markets · Exclusive

Gold hits three-month high as ETF inflows jump ahead of key data

Gold hits three-month high as ETF inflows jump ahead of key data
Markets · 2026
Photo · Marcus Devlin for Daily Digest Invest
By Marcus Devlin Equities Correspondent Aug 24, 2026 3 min read

Gold prices climbed to a three-month high this week, driven by a softer dollar and a surge in investor demand for gold-backed exchange-traded funds (ETFs). The move comes as markets position for two major events: Wednesday's release of the Federal Reserve's preferred inflation gauge, the PCE price index, and Friday's Jackson Hole Symposium, where central bankers gather to discuss policy.

Why gold is moving

The metal's rally isn't just about macro nerves—it's also about flows and momentum. According to Reuters, gold built on last week's big jump as the dollar slid. Because bullion is priced in dollars, a weaker greenback makes gold cheaper for buyers using other currencies, which can lift demand.

At the same time, gold moved back above its 200-day moving average, a widely watched trend line that can attract algorithmic and rules-based traders. Crossing this technical threshold often signals a shift in momentum, prompting some funds to add to their positions.

The fuel for the rally came from the World Gold Council, which reported that gold-backed ETFs added 46.7 metric tons last week. That marks a significant inflow, reflecting renewed interest from both retail and institutional investors who may be seeking a hedge against uncertainty.

What's on the horizon

Investors are now looking ahead to Wednesday's PCE inflation data, which could influence the Federal Reserve's next policy moves. If inflation comes in cooler than expected, it might reinforce expectations for rate cuts, which would typically be supportive for gold, as lower rates reduce the opportunity cost of holding non-yielding assets.

Friday's Jackson Hole Symposium, hosted by the Kansas City Fed, is another key catalyst. Central bank officials, including Fed Chair Jerome Powell, often use this venue to signal policy shifts. Markets will be listening for any hints about the timing and pace of future rate changes.

The dollar's recent weakness is also tied to these expectations. As we've seen, the dollar hit a three-month low amid Treasury buybacks and the looming symposium, which has added to gold's appeal.

What it means for investors

For everyday investors, the rise in gold prices and ETF inflows is a reminder that gold can play a role as a diversifier in a portfolio, especially during times of economic uncertainty. However, it's important to remember that gold doesn't pay interest or dividends, and its price can be volatile in the short term.

The recent inflows suggest that some investors are positioning for potential market turbulence or a shift in monetary policy. But it's also worth noting that gold's rally could fade if inflation data surprises to the upside or if the Fed signals a more hawkish stance than expected.

As always, it's wise to consider your own financial goals and risk tolerance before making any investment decisions. Gold can be a useful hedge, but it's not a one-size-fits-all solution.

Looking ahead, the key levels to watch are gold's ability to hold above its 200-day moving average and the reaction to the upcoming data. If the metal can sustain its gains, it could attract further buying; if not, we might see a pullback.

For now, the combination of a softer dollar, strong ETF inflows, and technical momentum has put gold back in the spotlight. Whether that translates into a longer-term trend will depend on the signals from the Fed and the broader economic data.

More from this story

Next article · Don't miss

Chip and pharma projects could lift US factory construction above $200B

UBS expects US factory construction to rebound, led by new chip and pharma projects. Manufacturing-related building could top $200 billion by end of next year after a recent slowdown.

Read the story →
Chip and pharma projects could lift US factory construction above $200B